US 12171818
Methods of isolating T cells having antigenic specificity for a cancer-specific mutation
granted A61KA61K2039/5158A61K2239/38
Quick answer
US patent 12171818 (Methods of isolating T cells having antigenic specificity for a cancer-specific mutation) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/5158, A61K2239/38, A61K39/0011, A61K40/11